Natalia Ovtcharenko
Biographic Data
| ID | 7754416 |
|---|---|
| NAME | Natalia Ovtcharenko |
| GIVEN NAMES | Natalia |
| FAMILY NAME | Ovtcharenko |
| SIGNATURE | OVTCHARENKO N |
| AFFILIATIONS | University of Toronto |
| VERIFIED | No |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 3 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2012 |
| LATEST PUBLICATION YEAR | 2014 |
| H-INDEX | 0 |
Why the MDGs need good governance in pharmaceutical systems to promote global health
Challenges identified in pharmaceutical governance initiatives manifest in different forms depending on the nature and structure of the initiative, but their regular occurrence and impact on population-based health demonstrates growing importance of addressing pharmaceutical governance as a key component of the post-2015 Millennium Development Goals. Specifically, these challenges need to be acknowledged and responded to with global cooperation a…
The make or buy debate
BACKGROUND: In order to ensure their population's regular access to essential medicines, many least developed countries and developing countries are faced with the policy question of whether to import or manufacture drugs locally, in particular for life-saving antiretroviral medicines for HIV/AIDS patients. In order for domestic manufacturing to be viable and cost-effective, the local industry must be able to compete with international suppliers …
An examination of pharmaceutical systems in severely disrupted countries
This research assesses informal markets that dominate pharmaceutical systems in severely disrupted countries and identifies areas for further investigation. Findings are based on recent academic papers, policy and grey literature, and field studies in Somalia, Afghanistan, the Democratic Republic of Congo and Haiti. The public sector in the studied countries is characterized in part by weak Ministries of Health and low donor coordination. Informa…
No prominent works on this page.
The make or buy debate
BACKGROUND: In order to ensure their population's regular access to essential medicines, many least developed countries and developing countries are faced with the policy question of whether to import or manufacture drugs locally, in particular for life-saving antiretroviral medicines for HIV/AIDS patients. In order for domestic manufacturing to be viable and cost-effective, the local industry must be able to compete with international suppliers …
An examination of pharmaceutical systems in severely disrupted countries
This research assesses informal markets that dominate pharmaceutical systems in severely disrupted countries and identifies areas for further investigation. Findings are based on recent academic papers, policy and grey literature, and field studies in Somalia, Afghanistan, the Democratic Republic of Congo and Haiti. The public sector in the studied countries is characterized in part by weak Ministries of Health and low donor coordination. Informa…
Why the MDGs need good governance in pharmaceutical systems to promote global health
Challenges identified in pharmaceutical governance initiatives manifest in different forms depending on the nature and structure of the initiative, but their regular occurrence and impact on population-based health demonstrates growing importance of addressing pharmaceutical governance as a key component of the post-2015 Millennium Development Goals. Specifically, these challenges need to be acknowledged and responded to with global cooperation a…
Economic growth (3 works) · Economics (3 works) · Law (3 works) · Medicine (3 works) · Pharmaceutical Economics and Policy (3 works) · Political science (3 works) · Public health (3 works) · Business (2 works) · Developing country (2 works) · Pharmaceutical Quality and Counterfeiting (2 works)